Transcriptomic analyses identified increased expression of STC1 (log2FC=2.02, p-adjusted (padj)=0.001), a secreted glycoprotein, and MKI67 (log2FC=1.11, padj=0.02), a common proliferation marker, in KS+KAD lesions, along with lower expression of cytokine-associated pathways. Here, STC1 is linked to Kaposi's sarcoma.